ArticleJournal of nephrology2024

Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience.

Marco Busutti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.